Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01748981
Other study ID # FALC-2010-OUSNIH
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2010
Est. completion date June 20, 2018

Study information

Verified date February 2019
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to investigate the change in pulmonary function and exercise capacity in lung cancer patients after pulmonary resection. Furthermore, to study the effect of training on aerobic capacity, muscular strength, morbidity and survival. Physical activity level by accelerometers, body composition by DXA and quality of life will also be reported.


Description:

Five year after surgery, all included patients will be reinvited to undergo a fourth health excame to study the long-term effects of exercise training on physical fitness, morbidity and survival.


Recruitment information / eligibility

Status Completed
Enrollment 71
Est. completion date June 20, 2018
Est. primary completion date December 2017
Accepts healthy volunteers No
Gender All
Age group 30 Years to 79 Years
Eligibility Inclusion Criteria:

- Non smal cell lung cancer

- Patient living in Oslo or Akershus county and accepted for lung cancer surgery at Oslo University hospital and Akershus University hospital

- were able to read and speak Norwegian

Exclusion Criteria:

- Mental incompetence or physical disability that makes it difficult to walk on a treadmill

- Treatment or medical complications affecting ability to participate in an exercise group

- > 79 years

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Physical training
Physical training three times a week for 20 week including endurance and strength training compare to the "as usual" group as controls
As usual
Controls, not training

Locations

Country Name City State
Norway Oslo University Hospital Oslo

Sponsors (4)

Lead Sponsor Collaborator
Oslo University Hospital Norwegian School of Sport Sciences, University Hospital, Akershus, Vestre Viken Hospital Trust

Country where clinical trial is conducted

Norway, 

References & Publications (1)

Edvardsen E, Skjønsberg OH, Holme I, Nordsletten L, Borchsenius F, Anderssen SA. High-intensity training following lung cancer surgery: a randomised controlled trial. Thorax. 2015 Mar;70(3):244-50. doi: 10.1136/thoraxjnl-2014-205944. Epub 2014 Oct 16. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other DXA scan Change in body composition from before to after surgery and after the intervention An expected average of two weeks before surgery, four to six weeks after surgery, after six months and after five years
Other Quality of life Change in quality of life from before to after surgery and after the intervention Measured three times: An expected average of two weeks before surgery, four to six weeks after surgery, after six months and after five years
Other Physical activity Physical activity will be objectively measured by accelerometers for seven consecutive days to determine change in activity level after surgery Measured three times: six weeks after surgery, after six months and after five years
Primary Change in Maximal oxygen uptake (VO2max) from baseline Change in VO2max from before to after surgery to measure the effect of surgery, and after six months to measure the effect of high-intensity training intervention, and after five years to study long-term effects An expected average of two weeks before surgery (baseline), four to six weeks after surgery, after six months and after 5 years
Secondary Change in Pulmonary function from baseline Change in pulmonary function from before to after surgery and after the intervention Pulmonary function is measured three times; an expected average of two weeks before surgery, four to six weeks after surgery, after after six months and after five years.
See also
  Status Clinical Trial Phase
Completed NCT03918538 - A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors N/A
Recruiting NCT05078918 - Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors N/A
Active, not recruiting NCT04548830 - Safety of Lung Cryobiopsy in People With Cancer Phase 2
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Not yet recruiting NCT06376253 - A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers Phase 1
Recruiting NCT05898594 - Lung Cancer Screening in High-risk Black Women N/A
Active, not recruiting NCT05060432 - Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT03667716 - COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. Phase 1
Active, not recruiting NCT03575793 - A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer Phase 1/Phase 2
Terminated NCT01624090 - Mithramycin for Lung, Esophagus, and Other Chest Cancers Phase 2
Terminated NCT03275688 - NanoSpectrometer Biomarker Discovery and Confirmation Study
Not yet recruiting NCT04931420 - Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels Phase 2
Recruiting NCT06010862 - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Phase 1
Recruiting NCT06052449 - Assessing Social Determinants of Health to Increase Cancer Screening N/A
Not yet recruiting NCT06017271 - Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Recruiting NCT05787522 - Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk